Home 의료 서비스 생명공학 Radiotheranostics Market

Radiotheranostics Market Size, Share & Trends Analysis Report By Radioisotope (Iodine-131, Iodine-123, Gallium-68, Lutetium-177, 18F with Y-90, Others), By Approach (Targeted Therapeutic, Targeted Diagnostic), By Application (Oncology, Thyroid Cancer, Neuroendocrine Tumor, Hepatocellular Carcinoma, Prostate Cancer, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

마지막 업데이트: June 25, 2026 | 저자: Dhanashri B | 형식: | 보고서 코드: SR7958DR | 페이지: 210
개요 목차 세분화 방법론
무료 샘플 다운로드

시장 세분화

  1. Radiotheranostics Market , By Radioisotope  2022-2034 (USD MILLION/ Units)
    1. Iodine-131
    2. Iodine-123
    3. Gallium-68
    4. Lutetium-177
    5. 18F with Y-90
    6. Others
  2. Radiotheranostics Market , By Approach  2022-2034 (USD MILLION/ Units)
    1. Targeted Therapeutic
    2. Targeted Diagnostic
  3. Radiotheranostics Market , By Application  2022-2034 (USD MILLION/ Units)
    1. Oncology
    2. Thyroid Cancer
    3. Neuroendocrine Tumor
    4. Hepatocellular Carcinoma
    5. Prostate Cancer
    6. Others
      1. Neurological Disorders
      2. Arthritis
      3. Others
  4. 지역별 Radiotheranostics Market
    1. North America
      1. North America Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      2. North America Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      3. North America Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
      4. U.S. Radiotheranostics Market
        1. U.S. Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. U.S. Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. U.S. Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      5. Canada Radiotheranostics Market
        1. Canada Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Canada Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Canada Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
    2. Europe
      1. Europe Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      2. Europe Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      3. Europe Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
      4. U.K. Radiotheranostics Market
        1. U.K. Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. U.K. Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. U.K. Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      5. Germany Radiotheranostics Market
        1. Germany Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Germany Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Germany Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      6. France Radiotheranostics Market
        1. France Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. France Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. France Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      7. Spain Radiotheranostics Market
        1. Spain Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Spain Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Spain Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      8. Italy Radiotheranostics Market
        1. Italy Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Italy Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Italy Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      9. Russia Radiotheranostics Market
        1. Russia Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Russia Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Russia Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      10. Nordic Radiotheranostics Market
        1. Nordic Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Nordic Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Nordic Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      11. Benelux Radiotheranostics Market
        1. Benelux Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Benelux Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Benelux Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      12. Rest of Europe Radiotheranostics Market
        1. Rest of Europe Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Rest of Europe Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Rest of Europe Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
    3. APAC
      1. APAC Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      2. APAC Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      3. APAC Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
      4. China Radiotheranostics Market
        1. China Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. China Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. China Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      5. Korea Radiotheranostics Market
        1. Korea Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Korea Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Korea Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      6. Japan Radiotheranostics Market
        1. Japan Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Japan Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Japan Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      7. India Radiotheranostics Market
        1. India Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. India Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. India Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      8. Australia Radiotheranostics Market
        1. Australia Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Australia Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Australia Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      9. Taiwan Radiotheranostics Market
        1. Taiwan Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Taiwan Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Taiwan Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      10. South East Asia Radiotheranostics Market
        1. South East Asia Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. South East Asia Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. South East Asia Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      11. Rest of Asia-Pacific Radiotheranostics Market
        1. Rest of Asia-Pacific Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Rest of Asia-Pacific Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Rest of Asia-Pacific Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
    4. Middle East and Africa
      1. Middle East and Africa Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      2. Middle East and Africa Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      3. Middle East and Africa Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
      4. UAE Radiotheranostics Market
        1. UAE Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. UAE Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. UAE Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      5. Turkey Radiotheranostics Market
        1. Turkey Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Turkey Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Turkey Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      6. Saudi Arabia Radiotheranostics Market
        1. Saudi Arabia Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Saudi Arabia Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Saudi Arabia Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      7. South Africa Radiotheranostics Market
        1. South Africa Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. South Africa Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. South Africa Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      8. Egypt Radiotheranostics Market
        1. Egypt Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Egypt Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Egypt Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      9. Nigeria Radiotheranostics Market
        1. Nigeria Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Nigeria Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Nigeria Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      10. Rest of MEA Radiotheranostics Market
        1. Rest of MEA Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Rest of MEA Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Rest of MEA Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
    5. LATAM
      1. LATAM Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
        1. Iodine-131
        2. Iodine-123
        3. Gallium-68
        4. Lutetium-177
        5. 18F with Y-90
        6. Others
      2. LATAM Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
        1. Targeted Therapeutic
        2. Targeted Diagnostic
      3. LATAM Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Thyroid Cancer
        3. Neuroendocrine Tumor
        4. Hepatocellular Carcinoma
        5. Prostate Cancer
        6. Others
          1. Neurological Disorders
          2. Arthritis
          3. Others
      4. Brazil Radiotheranostics Market
        1. Brazil Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Brazil Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Brazil Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      5. Mexico Radiotheranostics Market
        1. Mexico Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Mexico Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Mexico Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      6. Argentina Radiotheranostics Market
        1. Argentina Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Argentina Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Argentina Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      7. Chile Radiotheranostics Market
        1. Chile Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Chile Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Chile Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      8. Colombia Radiotheranostics Market
        1. Colombia Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Colombia Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Colombia Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
      9. Rest of LATAM Radiotheranostics Market
        1. Rest of LATAM Radiotheranostics Market By Radioisotope  2022-2034 (USD MILLION/ Units)
          1. Iodine-131
          2. Iodine-123
          3. Gallium-68
          4. Lutetium-177
          5. 18F with Y-90
          6. Others
        2. Rest of LATAM Radiotheranostics Market By Approach  2022-2034 (USD MILLION/ Units)
          1. Targeted Therapeutic
          2. Targeted Diagnostic
        3. Rest of LATAM Radiotheranostics Market By Application  2022-2034 (USD MILLION/ Units)
          1. Oncology
          2. Thyroid Cancer
          3. Neuroendocrine Tumor
          4. Hepatocellular Carcinoma
          5. Prostate Cancer
          6. Others
            1. Neurological Disorders
            2. Arthritis
            3. Others
200+ 신뢰할 수 있는 파트너
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
무료 샘플 다운로드
문의해 주세요
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

다음 매체에 소개되었습니다:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.